9th Translational Research Conference: Myelodysplastic Syndromes

Conference Details

Date: 12 April 2024

Time: To be announced

Duration: 3 days

Location: Budapest Marriott Hotel, Budapest, Hungary

Cost: Register online for more information.

Organiser: ESH - European School of Haematology

Conference Website

Conference Description

ESH 9^th TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease.

New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

LEARNING OBJECTIVES:

Upon completion of this CME activity, participants should be able to:

• Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis;
• Improve ability to analyse prognostic factors, including new ones (revised IPSS, molecular analysis);
• Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation;
• Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials.

SCIENTIFIC TOPICS:

• The sinister origins of MDS;
• The interplay between MDS, inflammatory, and immune abnormalities;
• What’s in a name? Classifying MDS;
• New tools to explore MDS;
• Special populations;
• Treatment of lower-risk MDS;
• Treatment of higher-risk MDS;
• Transplantation;
• Clinical trials in MDS/CMML: cooperative groups.

THE PROGRAMME WILL INCLUDE:

• Plenary Sessions;
• Panel Discussions;
• Roundtables;
• Simultaneous Meet the Expert Sessions;
• Poster Walks;
• Brief Oral Communications.